4-Mercapto-4-methyl-2-pentanol
Common Name: |
4-Mercapto-4-methyl-2-pentanol |
IUPAC Name: |
4-methyl-4-sulfanylpentan-2-ol |
Molecular Formula: |
C6H14OS |
SMILES: |
CC(CC(C)(C)S)O |
Inchi: |
1S/C6H14OS/c1-5(7)4-6(2,3)8/h5,7-8H,4H2,1-3H3 |
Inchi Key: |
FDBQLLMYSACLPB-UHFFFAOYSA-N |
Cas No: |
31539-84-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
134.24 |
Mass (g/mol) |
134.077 |
Molar Refractivity |
40.08 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
2 |
Rings |
|
TPSA |
59.03 |
Hetero Atoms |
2 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
50.00 to 51.00 @ 1.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.095 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.466 |
iLOGP |
1.86 |
XLOGP3 |
1.24 |
WLOGP |
1.47 |
MLOGP |
1.53 |
ESOL Log S |
-1.32 |
ESOL Solubility (mg/ml) |
6.4 |
ESOL Solubility (mol/l) |
0.048 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.08 |
Ali Solubility (mg/ml) |
1.12 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.05 |
Silicos-IT Solubility (mg/ml) |
12.1 |
Silicos-IT Solubility (mol/l) |
0.09 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.24 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.124 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.964 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |